The Society of Gynecologic Oncology recommends genetic testing for individuals with a high tendency for familial cancer (a first-degree or several close relatives with an inherited predisposition, a close relative carrying known BRCA1 or BRCA2 mutations, and a close relative with male breast cancer) (25). This evidence concerns the gene BRCA1 and breast carcinoma.